Glutathione Tablets (Tathion) are an important endogenous detoxification drug. Mastering the correct handling methods for missed and overdosed doses is of great significance for ensuring medication safety and therapeutic efficacy.
Mechanism of Action and Drug Interactions of Glutathione Tablets
1. Detailed Mechanism of Action
The biological activity of glutathione exerts its effects through two mechanisms:
(1) Redox reaction mechanism: The glutathione molecule contains an active sulfhydryl group (-SH), which participates in redox reactions in the body. It can maintain an appropriate reducing environment inside cells and protect cells from oxidative damage. During detoxification, reduced glutathione can bind to toxic substances and convert them into excretable metabolites.
(2) Non-redox reaction mechanism: Glutathione also acts as a coenzyme in various biochemical reactions. It plays a role in the generation of thiolic acids and participates in the detoxification mechanism; it protects and activates sulfhydryl-containing enzymes and other cellular components; and it plays an important role in cell division and proliferation. These functions make it indispensable for maintaining the normal physiological activities of cells.
2. Pharmacokinetics
2.1 Absorption
(1) Animal experiments have shown that after oral administration of glutathione, it is rapidly absorbed from the small intestine, and most of it remains in the form of reduced glutathione when entering the portal venous blood.
(2) Glutathione in the blood rapidly binds to serum proteins, with approximately 70-80% existing in a bound form.
2.2 Metabolism
(1) One hour after oral administration, the proportion of glutathione prototype and its metabolites in urine is as follows: prototype 14.3%, cysteine 33.0%, oxidized glutathione 11.5%, and other metabolites 41.2%.
(2) This indicates that glutathione is extensively metabolized in the body and converted into a variety of active substances.
2.3 Excretion
(1) After oral administration of isotope-labeled glutathione to rats, the urinary excretion rate within 24 hours was 18.3-38.8%, and the fecal excretion was only 1.18%.
(2) This shows that glutathione is mainly excreted via the kidneys, with very little intestinal excretion.
3. Pharmacological Effects and Clinical Efficacy
(1) Glutathione exhibits therapeutic effects in various poisoning states: it alleviates symptoms of methylmercury poisoning in rats; it is effective for lead poisoning in humans; it improves organophosphorus pesticide poisoning in humans; and it provides protection against sulfur dioxide gas poisoning in mice and rats.
(2) Clinical studies have shown that the effective rate of glutathione for toxic diseases (including drug poisoning, pesticide poisoning, metal poisoning, autointoxication, etc.) is 94.5% (225/238 cases). The effective rate for pregnancy toxemia (including hyperemesis gravidarum and late pregnancy toxemia) is 77.9% (148/190 cases). A double-blind controlled trial targeting hyperemesis gravidarum has also confirmed the efficacy of this drug.
4. Drug Interactions
Research data on the drug interactions of Glutathione Tablets with other drugs are limited. However, based on its mechanism of action, the following situations require attention:
(1) When combined with drugs that require hepatic metabolic detoxification, it may enhance the liver's detoxification capacity.
(2) It may affect the metabolism of sulfhydryl-containing drugs.
(3) As an antioxidant, it may produce synergistic or additive effects with other antioxidants.
(4) If you are taking other drugs, you should inform your doctor before taking this drug, and the doctor will evaluate whether it is necessary to adjust the medication regimen.
Management of Missed and Overdosed Doses of Glutathione Tablets
1. Standard Dosage and Administration
(1) Calculated based on reduced glutathione, the conventional adult dose of Glutathione Tablets is 50-100 mg per time, taken orally 1-3 times a day.
(2) The specific dosage should be appropriately adjusted according to the patient's age and severity of symptoms. Medication should be taken as directed by a doctor, and the dosage should not be increased or decreased without authorization.
2. Correct Handling of Missed Doses
(1) Handling occasional missed doses: If you forget to take one dose, take it as soon as you remember.
(2) However, if it is close to the next dose time (e.g., the interval is less than 4-6 hours), the missed dose should be skipped, and the next normal dose should be taken as originally scheduled.
(3) Do not take a double dose at one time due to a missed dose.
3. Measures for Handling Overdosed Doses
3.1 Handling of mild overdose
(1) If you accidentally take a slightly higher dose than the prescribed amount and have no obvious discomfort symptoms, you can drink more water to promote drug excretion and closely observe the body's reaction.
(2) Take the next dose on time and in the prescribed amount without adjustment.
3.2 Handling of significant overdose
(1) If you take a dose far exceeding the prescribed amount, or if any discomfort symptoms occur, you should consult a doctor or pharmacist immediately.
(2) If you cannot contact medical staff, you should go to the emergency department of a nearby hospital for treatment.
(3) Bring the drug packaging or instructions when seeking medical treatment, and inform the doctor of the dosage and time of taking the drug.
4. Issues Related to Drug Discontinuation
(1) When Glutathione Tablets are used for the treatment of acute poisoning, the drug can usually be discontinued under the guidance of a doctor after the symptoms are relieved.
(2) When used for chronic diseases or pregnancy-related symptoms, the prescribed course of treatment should be completed as directed by a doctor, and the drug should not be discontinued prematurely without authorization.
(3) If you need to discontinue the drug, you should consult a doctor for advice.
(4) Abrupt discontinuation generally does not cause withdrawal reactions, but it may lead to the recurrence or aggravation of the original symptoms.
(5) The doctor will decide whether gradual dose reduction is required to discontinue the drug based on the patient's condition.
